Veterinary Medicines

PARVOKAN

Authorised
  • Derzsy's disease virus, strain H, Live
  • Muscovy duck parvovirus, strain GM, Inactivated
Download as PDF

Product identification

Medicine name:
PARVOKAN
PARVOKAN
Active substance:
  • Derzsy's disease virus, strain H, Live
  • Muscovy duck parvovirus, strain GM, Inactivated
Target species:
  • Duck
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Derzsy's disease virus, strain H, Live
    2.50
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
  • Muscovy duck parvovirus, strain GM, Inactivated
    1.50
    log10 serum neutralising unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Duck
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01BH01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • Box of one 1,500-dose bottle of suspension and three 500-dose bottles of freeze-dried pellet
  • Box of ten 500-dose bottles of suspension and ten 500-dose bottles of freeze-dried pellet
  • Box of ten 1,500-dose bottles of suspension and thirty 500-dose bottles of freeze-dried pellet
  • Box of one 500-dose bottle of suspension and one 500-dose bottle of freeze-dried pellet

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/5823169 2/2002
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0144/001
Concerned member states:
  • Germany
  • Italy

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."